FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885188023> ?p ?o ?g. }

• W2885188023 endingPage "8" @default.
• W2885188023 startingPage "1" @default.
• W2885188023 abstract "Objective: To investigate the clinical and radiographic status, and to identify baseline predictors of functional status and erosive progression at 11 years’ follow-up of early rheumatoid arthritis (RA) patients.Methods: Patients enrolled in the Danish investigator-initiated randomized controlled CIMESTRA trial, which investigated a 2 year treat-to-target intervention with methotrexate and intra-articular glucocorticoids with or without cyclosporine, were followed up. The 28-joint Disease Activity Score (DAS28), Health Assessment Questionnaire (HAQ) score, and total Sharp van der Heijde score (TSS) were assessed at baseline and 11 years. Baseline magnetic resonance imaging (MRI) of unilateral wrists was scored (OMERACT RAMRIS). Multivariable linear regression analyses of baseline variables [TSS, HAQ, DAS28, age, anti-cyclic citrullinated peptide (anti-CCP) status, gender, MRI erosion score, MRI synovitis score, MRI bone marrow oedema score] were performed in 96 patients with HAQ11yrs and ∆TSS0–11yrs as dependent variables. Since outcomes were similar in the two treatment arms, data were pooled.Results: In total, 120 of 160 patients completed 11 years’ follow-up. They were 63 (55–72) years old, 68% were in DAS28 remission (≤ 2.4), HAQ11yrs was 0.25 (0–0.75), mean ∆TSS0–11yrs was 0.96 ± 1.52 units/year; 53%, 20%, and 27% received conventional treatment, biologics, and no treatment, respectively; and 34% had not progressed radiographically since baseline. Increased DAS28 (p = 0.02) and anti-CCP (p = 0.03) predicted HAQ11yrs, whereas anti-CCP (p = 0.03) and MRI bone marrow oedema (p = 0.01) predicted ∆TSS0–11yrs in multivariable analyses.Conclusions: Early and strict synovitis suppression with methotrexate and intra-articular glucocorticoids led to persistently high remission rates and limited erosive progression at 11 years. In this well-treated cohort, baseline anti-CCP status, DAS28, and MRI bone marrow oedema predicted functional status and/or erosive progression." @default.
• W2885188023 created "2018-08-22" @default.
• W2885188023 creator A5004910716 @default.
• W2885188023 creator A5007128043 @default.
• W2885188023 creator A5010403338 @default.
• W2885188023 creator A5025277801 @default.
• W2885188023 creator A5029636602 @default.
• W2885188023 creator A5034395246 @default.
• W2885188023 creator A5042428908 @default.
• W2885188023 creator A5056189838 @default.
• W2885188023 creator A5063586848 @default.
• W2885188023 creator A5066072640 @default.
• W2885188023 creator A5072664936 @default.
• W2885188023 creator A5086180632 @default.
• W2885188023 creator A5091382037 @default.
• W2885188023 date "2018-08-13" @default.
• W2885188023 modified "2023-10-17" @default.
• W2885188023 title "Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years’ functional and radiographic outcome in early rheumatoid arthritis" @default.
• W2885188023 cites W1974015269 @default.
• W2885188023 cites W2004776451 @default.
• W2885188023 cites W2025314662 @default.
• W2885188023 cites W2031388906 @default.
• W2885188023 cites W2040515772 @default.
• W2885188023 cites W2051728683 @default.
• W2885188023 cites W2078317963 @default.
• W2885188023 cites W2101387806 @default.
• W2885188023 cites W2110177517 @default.
• W2885188023 cites W2115068422 @default.
• W2885188023 cites W2124713130 @default.
• W2885188023 cites W2135436310 @default.
• W2885188023 cites W2142004396 @default.
• W2885188023 cites W2149768460 @default.
• W2885188023 cites W2151476793 @default.
• W2885188023 cites W2152348310 @default.
• W2885188023 cites W2153255333 @default.
• W2885188023 cites W2161847163 @default.
• W2885188023 cites W2162002325 @default.
• W2885188023 cites W2162351377 @default.
• W2885188023 cites W2168125040 @default.
• W2885188023 cites W2265480239 @default.
• W2885188023 cites W2336100848 @default.
• W2885188023 cites W4211019157 @default.
• W2885188023 cites W4295125684 @default.
• W2885188023 doi "https://doi.org/10.1080/03009742.2018.1466362" @default.
• W2885188023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30101636" @default.
• W2885188023 hasPublicationYear "2018" @default.
• W2885188023 type Work @default.
• W2885188023 sameAs 2885188023 @default.
• W2885188023 citedByCount "14" @default.
• W2885188023 countsByYear W28851880232019 @default.
• W2885188023 countsByYear W28851880232020 @default.
• W2885188023 countsByYear W28851880232021 @default.
• W2885188023 countsByYear W28851880232022 @default.
• W2885188023 countsByYear W28851880232023 @default.
• W2885188023 crossrefType "journal-article" @default.
• W2885188023 hasAuthorship W2885188023A5004910716 @default.
• W2885188023 hasAuthorship W2885188023A5007128043 @default.
• W2885188023 hasAuthorship W2885188023A5010403338 @default.
• W2885188023 hasAuthorship W2885188023A5025277801 @default.
• W2885188023 hasAuthorship W2885188023A5029636602 @default.
• W2885188023 hasAuthorship W2885188023A5034395246 @default.
• W2885188023 hasAuthorship W2885188023A5042428908 @default.
• W2885188023 hasAuthorship W2885188023A5056189838 @default.
• W2885188023 hasAuthorship W2885188023A5063586848 @default.
• W2885188023 hasAuthorship W2885188023A5066072640 @default.
• W2885188023 hasAuthorship W2885188023A5072664936 @default.
• W2885188023 hasAuthorship W2885188023A5086180632 @default.
• W2885188023 hasAuthorship W2885188023A5091382037 @default.
• W2885188023 hasBestOaLocation W28851880232 @default.
• W2885188023 hasConcept C126322002 @default.
• W2885188023 hasConcept C126838900 @default.
• W2885188023 hasConcept C143409427 @default.
• W2885188023 hasConcept C198451711 @default.
• W2885188023 hasConcept C2777575956 @default.
• W2885188023 hasConcept C2779244835 @default.
• W2885188023 hasConcept C71924100 @default.
• W2885188023 hasConceptScore W2885188023C126322002 @default.
• W2885188023 hasConceptScore W2885188023C126838900 @default.
• W2885188023 hasConceptScore W2885188023C143409427 @default.
• W2885188023 hasConceptScore W2885188023C198451711 @default.
• W2885188023 hasConceptScore W2885188023C2777575956 @default.
• W2885188023 hasConceptScore W2885188023C2779244835 @default.
• W2885188023 hasConceptScore W2885188023C71924100 @default.
• W2885188023 hasIssue "1" @default.
• W2885188023 hasLocation W28851880231 @default.
• W2885188023 hasLocation W28851880232 @default.
• W2885188023 hasLocation W28851880233 @default.
• W2885188023 hasOpenAccess W2885188023 @default.
• W2885188023 hasPrimaryLocation W28851880231 @default.
• W2885188023 hasRelatedWork W1966829184 @default.
• W2885188023 hasRelatedWork W2041734676 @default.
• W2885188023 hasRelatedWork W2052332647 @default.
• W2885188023 hasRelatedWork W2052664721 @default.
• W2885188023 hasRelatedWork W2071023694 @default.
• W2885188023 hasRelatedWork W2080876443 @default.
• W2885188023 hasRelatedWork W2086657643 @default.
• W2885188023 hasRelatedWork W2336002261 @default.
• W2885188023 hasRelatedWork W2925118230 @default.

• next